Xcell and aCGT Vector partner on cell and gene therapy development
Pharmaceutical Technology
OCTOBER 14, 2022
Pharmaceutical companies Xcell Biosciences (Xcellbio) and aCGT Vector have partnered to expedite the development of cell and gene therapies. The two companies will aim to improve the manufacturing and analytic procedures used to develop personalised cell and gene therapies to treat cancer patients.
Let's personalize your content